Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nasdaq  >  Sucampo Pharmaceuticals, Inc.    SCMP

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
07/24/2015 07/27/2015 07/28/2015 07/29/2015 07/30/2015 Date
22.1(c) 21.64(c) 22.71(c) 21.39(c) 20.9(c) Last
1 086 349 525 985 879 424 754 508 492 682 Volume
+12.76% -2.08% +4.94% -5.81% -2.29% Change
More quotes
Financials ($)
Sales 2015 132 M
EBIT 2015 46,6 M
Net income 2015 28,5 M
Debt 2015 -
Yield 2015 -
Sales 2016 155 M
EBIT 2016 62,9 M
Net income 2016 38,0 M
Debt 2016 -
Yield 2016 -
PER 2015 33,89
PER 2016 25,49
Capi. / Sales 2015 7,15x
Capi. / Sales 2016 6,09x
Capitalization 944 M
More Financials
Company
Sucampo Pharmaceuticals, Inc. is a biopharmaceutical company which engages in research, discovery, development and commercialization of proprietary drugs in the Americas, Europe and Asia.It is developing prostones, which are ion channel activators, to treat gastrointestinal, ophthalmic and... 
More about the company
Surperformance© ratings of Sucampo Pharmaceuticals, I
Trading Rating : Investor Rating :
More Ratings
Latest news on SUCAMPO PHARMACEUTICALS, I
07/24 SUCAMPO PHARMACEUTICALS : Technical Report on Drug Manufacturers - Other Stocks ..
07/23 SUCAMPO PHARMACEUTICALS : Announces Second Quarter 2015 Earnings Call
07/22 Sucampo Announces Second Quarter 2015 Earnings Call
07/08 SUCAMPO PHARMACEUTICALS : Regulation FD Disclosure, Financial Statements and Exh..
07/02 SUCAMPO PHARMACEUTICALS : Announces Webcast of Its Presentation at Cantor Fitzge..
07/01 SUCAMPO PHARMACEUTICALS : Announces Webcast of Its Presentation at Cantor Fitzge..
06/15 China Food and Drug Administration Accepts IND for Pivotal Study of AMITIZA(R..
05/29 SUCAMPO PHARMACEUTICALS : Submission of Matters to a Vote of Security Holders (f..
More news
Sector news : Bio Therapeutic Drugs
07/30 SEATTLE GENETICS : reports 2Q loss
07/30 QUINTILES TRANSNATIONAL : Announces Launch of Secondary Public Offering of Commo..
07/30 SEATTLE GENETICS : Reports Second Quarter 2015 Financial Results
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
07/27 PREMARKET BIOTECH DIGEST : Gilead Earnings Tomorrow, Praluent, Other Approvals
07/07 After Hours Gainers / Losers
06/18 Synergy Longs Now Have The Upper Hand
06/05 After Hours Gainers / Losers
05/17 WEEK IN REVIEW : BeiGene Raises $97 Million For Cancer Drugs


Comments 
Advertisement
Chart SUCAMPO PHARMACEUTICALS, I
Duration : Period :
Sucampo Pharmaceuticals, I Technical Analysis Chart | SCMP | US8649091068 | 4-Traders
Full-screen chart
Technical analysis trends SUCAMPO PHARMACEU...
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions